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Abstract
The requirement for correct dosage of the transcription factor Pax6 during corneal growth and
development was investigated using the Pax6-overexpressing (PAX77) transgenic mouse.
Transgenics had a microcornea phenotype due to failure of postnatal growth, associated with
reduction in the number of cells layers in the corneal epithelium. Cell cycle progression was
monitored using bromodeoxyuridine, p63, cyclin E, and phosphohistone-3 labeling: proliferation
rates were higher in PAX77+ than wild-type, without a concomitant increase in apoptosis. Hence,
failure of proliferation did not underlie microcornea. PAX77+ corneal epithelia had reduced levels
of cytokeratin-12, and exhibited severe wound healing delay that, in contrast to Pax6+/- mice,
could not be modulated by exogenous growth factors. PAX77+ lenses showed partial failure of
lens fiber differentiation. The data demonstrate that anterior eye development is very sensitive to
Pax6 dosage. Although there are similarities between the eye phenotype of Pax6 heterozygotes
and overexpressing mice, there are also striking differences.
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INTRODUCTION
Development of the mammalian cornea, in terms of growth, stratification, differentiation,
and initiation of patterns of cell migration is substantially a postnatal event, taking several
months even in mice (Collinson et al., 2002). The PAX6 gene encodes a transcription factor,
essential for normal development of the mammalian eye (e.g., Ton et al., 1991; Hill et al.,
1991; Grindley et al., 1995). Pax6 expression is down-regulated in many adult tissues, but it
is maintained in the corneal epithelium (Koroma et al., 1997), where it is involved in
maintenance and in wound healing (Chao et al., 2000; Sivak et al., 2000; Sivak et al., 2004;
Baulmann et al., 2002; Davis et al., 2003; Leiper et al., 2006; Ramaesh et al., 2006). Corneal
abnormalities of the Pax6 heterozygous mouse have been well documented (Baulmann et
al., 2002; Davis et al., 2003; Ramaesh et al., 2003, 2005a, 2006) and are similar to the
changes seen in human PAX6+/- aniridia (Nishida et al., 1995). Aniridia is a sight-
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threatening bilateral pan-ocular condition in which the development of the iris, retina, lens,
and cornea is disturbed (Shaw, 1960; Nelson et al., 1984; Churchill et al., 2000; Ramaesh at
al., 2005b). Marked changes in the corneal epithelium are seen in aniridic patients, which
can culminate in corneal opacification leading to visual loss (Nelson et al., 1984, Ramaesh et
al., 2005b).
Limbal stem cell deficiency is in part responsible for the corneal changes in PAX6+/-
individuals (Cotsarelis et al., 1996; Holland et al., 2003; Collinson et al., 2004; Ramaesh et
al., 2005b). However, other factors play a role, including abnormal corneal differentiation
leading to fragility of corneal epithelial cells, an abnormal epithelial response to wounding
due to inefficient cell-cell signalling mechanisms, and abnormal cell migration and adhesion
(Davis et al., 2003; Collinson et al., 2004; Ramaesh et al., 2005a; Leiper at al., 2006;
Kucerova et al., 2006).
The production of the PAX77 transgenic mouse model (Schedl et al., 1996) suggested that
Pax6 overexpression also interfered with normal eye development. Schedl et al. (1996)
showed that there is a reduction in overall eye size in PAX77+ mice, which carry five to
seven copies of a 500-Mb YAC-based transgene containing the human PAX6 locus and
overexpressing PAX6 in a tissue-specific pattern that recapitulates that of the endogenous
gene. The transgenic mice exhibited microcornea, and their corneas were transparent. Some
of the features of the PAX77 mouse described in Schedl et al. (1996; cataract,
microphthalmia) suggested similarities to the Pax6+/- mouse. Thus, it was postulated that
both under and overexpression of Pax6 lead to similar developmental defects.
Alternative splicing of exon 5a yields two major protein isoforms, Pax6 and Pax6(5a).
Transgenic mice overexpressing human Pax6 or Pax6(5a) in the lens develop cataracts with
abnormalities in fiber cell and shape as well as fiber cell/lens capsule and fiber cell/fiber cell
interactions (Duncan et al., 2000, 2004). Relatively small changes in the Pax6 and Pax6(5a)
ratio may be important, because the two isoforms affect different downstream target genes
(Epstein et al., 1994). The overexpression of Pax6 or Pax6(5a) isoforms in various systems
has highlighted the effects of specific isoforms on gene expression and eye development
(Chauhan et al., 2002a,b; Pinson et al., 2005). Therefore, the regulation of the relative levels
of the two isoforms is very important for normal development (Duncan et al., 2004). The
intact Pax6 locus is subject to positive autoregulation and this might provide a mechanism
that stabilizes the relative levels of the two major isoforms of Pax6 (Duncan et al., 2004).
Aalfs et al. (1997) reported a human case of PAX6 overexpression due to duplication of
chromosome band 11p12→13, which includes the Wilms’ tumor gene (WT1) and PAX6.
This resulted in borderline developmental abnormalities, mild facial anomalies, and eye
abnormalities. A reduction in overall eye size was reported along with transparent, small
corneas. The phenotypic features of the PAX77 mouse (Schedl et al., 1996) are comparable
to those seen in the duplication of human 11p12→13, suggesting a detrimental effect of
extra copies of PAX6 on eye development in both mice and humans (Aalfs et al., 1997). The
PAX77 mouse is, therefore, a model of human microcornea.
While it is clear that the overexpression of Pax6 has an adverse effect on eye development,
little work has focused on the effects of increased expression of Pax6 on corneal structure
and function. Therefore, the purpose of this study was to investigate the effects of Pax6
overexpression for corneal development and function in the PAX77 transgenic mouse
model.
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RESULTS
Histological Analysis of the Anterior Segment of the PAX77+ Eyes
Hematoxylin and eosin staining of PAX77+ eyes revealed morphological differences in the
anterior segment compared with wild-type, although the corneas looked relatively normal in
tissue section. At postnatal day (P) 2 in both genotypes, the corneal epithelium consisted of a
single layer of cells. Stratification was evident at P10 (Fig. 1A,B), and two to six cell layers
were observed in adults (Fig. 1C,D) (analyzed quantitatively below). Periodic acid-Schiff
(PAS) reagent staining did not detect the presence of ectopic conjunctival goblet cells in the
PAX77+ corneal epithelia in contrast to Pax6+/- (Ramaesh et al., 2005a). Corneal stromal
lamination and the collagen fiber lattice were normal in PAX77+ (Fig. 1E,F). All PAX77+
eyes at all ages lacked ciliary bodies (Fig. 1G,H). Irides of the PAX77+ mice were
hypertrophic in comparison to the wild-type, with cyst like structures as described by Schedl
et al. (1996; Supplementary Figure S1, which can be viewed at http://
www.interscience.wiley.com/jpages/10588388/suppmat).
Failure of Postnatal Growth and Fewer Cell Layers in the PAX77+ Corneal Epithelium
At P2, corneal diameter was slightly, but significantly smaller in the PAX77+ (mean ± SEM:
1.27 ± 0.024 mm; n = 10) than wild-type (1.49 ± 0.017 mm; n = 10; unpaired t-test: P <
0.0001). At older stages, the differences between wild-type and PAX77+ were very obvious
(Fig. 2A). Corneal diameter of P10 PAX77+ mice was significantly smaller (mean ± SEM:
1.23 ± 0.0295 mm; n = 12) than wild-type (2.21 ± 0.061 mm; n = 12; unpaired t-test: P <
0.0001), and the size difference was particularly noticeable in adults (PAX77+: 1.4 ± 0.06
mm, n = 12; wild-type: 3.39 ± 0.04 mm, n = 16; unpaired t-test: P < 0.0001). The etiology of
PAX77+ microcornea is, hence, a failure of postnatal growth following relatively normal
embryonic development.
For quantitative analysis, transverse tissue sections of the corneal epithelium were divided
into four equal regions as described in the Experimental Procedures section, with the two
outer sectors representing the peripheral cornea and the two inner sectors the central cornea.
In the adult PAX77+ mice, the corneal epithelium was made up of fewer cell layers than
wild-type in both central and peripheral areas of the cornea (PAX77+ peripheral mean ±
SEM: 2.77 ± 0.19 layers vs. wild-type 4.04 ± 0.12, P < 0.001 by unpaired t-test; PAX77+
central mean ± SEM: 3.4 ± 0.27 vs. wild-type 4.8 ± 0.1, P < 0.01 by unpaired t-test). In
some cases, the cell layers appeared to be disorganized when compared with the wild-type.
Morphometric analysis of adult tissue sections was performed (Fig. 2B). In both genotypes,
the corneal epithelium was significantly thicker in central regions than at the periphery
(paired t-test: P < 0.001 in the wild-type and P < 0.05 in PAX77+). The PAX77+ corneal
epithelium was significantly thinner in peripheral regions compared with the wild-type
(unpaired t-test: P < 0.05). Although fewer cell layers were detected in PAX77+ corneal
epithelial, there was no significant difference in thickness of the epithelium between the two
genotypes in central corneal regions, suggesting a change in cell shape in the
PAX77+compared with wild-type. There were no differences seen in the thickness of the
stroma and endothelium between the two genotypes.
Pax6 Expression in the PAX77+ Eye Is Up-regulated
Pax6 was expressed in a tissue-appropriate manner in PAX77+ eyes at all ages at levels
higher than those observed for wild-type (Fig. 3). Western blot of adult corneas was
performed and quantified against β-actin loading control, confirming that Pax6 was
expressed at significantly higher levels in the PAX77+ corneas at this age compared with
wild-type littermates (mean 2.24-fold difference; Fig. 3B,C). The ratio of Pax6 : Pax6(5a)
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isoforms was also quantified on Western blots, where, for wild-type adult controls. this ratio
was 5.35 ±0.67 (n = 5) and for littermates was 3.97 ±0.45 (n = 7). The difference was not
significant by Mann-Whitney U test (U = 26; P = 0.20). Semiquantitative
immunohistochemical analysis for Pax6 expression (Leiper et al., 2006) was performed by
measuring the intensity of fluorescence of individual nuclei from corneal sections of wild-
type and PAX77+ littermates after immunohistochemistry performed and photographed in
parallel using an Alexa 488-tagged anti-mouse IgG1 secondary antibody. At postnatal day 2,
before onset of phenotypic changes, mean nuclear fluorescence (derived from luminosity
histogram, Adobe Photoshop, arbitrary units) of wild-type corneal epithelia was 34.6 ± 2.48
(n = 68), significantly less than that of PAX77+, 56.3 ± 2.49 (t-test: P < 0.0001). By this
estimate, PAX77+ P2 neonates, therefore, expressed 1.63-fold more Pax6 in the corneal
epithelium than their wild-type littermates.
Cell Cycle Progression Is Not Retarded in the PAX77+ Corneal Epithelium
Because PAX77+ corneas did not grow significantly after birth, cell proliferation was
investigated in both eyes from four adult PAX77+ mice and four adult wild-type mice by
immunohistochemistry following intraperitoneal injection of bromodeoxyuridine (BrdU) as
described in the Experimental Procedures section. In the corneal epithelium of both
genotypes, BrdU-positive cells were restricted to the basal layer. In both wild-type and
PAX77+, the percentage of BrdU-positive cells in the corneal epithelium did not differ
significantly from peripheral to central regions (paired t tests: wild-type P = 0.35, PAX77+ P
= 0.87). The percentage of S-phase cells (BrdU-positive nuclei) was significantly higher in
the PAX77+ epithelia in both the peripheral and central regions of the cornea (peripheral
mean ± SEM: PAX77+ = 13.42 ± 1.28%, wild-type = 7.66 ± 0.76%, P < 0.001 by unpaired
t-test; central mean ± SEM: PAX77+ = 13.85 ± 1.31%, wild-type = 6.11 ± 1.31, P < 0.01 by
unpaired t-test; Fig. 4A,B).
Antisera against phospho-histone H3 (PH3) were used to detect mitotic cells in the corneal
epithelia at all ages, but the very small proportion of labeled cells precluded a quantitative
analysis (data not shown). PH3+ cells were noted in both wild-type and PAX77+ corneal
epithelia.
Cyclin E staining was used as a marker for cells around the G1/S transition. Staining was
primarily localized to the nuclei of the basal epithelium, and the proportion of positive cells
was counted as above, separately for central and peripheral cornea. No significant difference
was found in the proportion of cyclin E+ cells between the genotypes except in the
peripheral cornea at P10, for which 73.7% ± 0.74 (n = 10) of PAX77+ corneal epithelial
cells were cyclin E+, compared with 78.0% ± 0.688 (n = 10) of wild-types (Table 1). This
may hint at problems with the cell cycle progression in the peripheral cornea at the critical
stage of PAX77+ corneal growth. Although highly significant (t-test: P = 0.0001), the
difference is relatively small and restricted to peripheral cornea, so its biological
significance may be minor.
p63 Is Expressed at Higher Frequency in the Basal Layer of the PAX77+ Corneal
Epithelium Than in Wild-type
P63 is a marker for stem-like cells and cells with high proliferative potential in the corneal
epithelium (Pellegrini et al., 2002; Ramaesh et al., 2003; Senoo et al., 2007). Both eyes from
four wild-type and four PAX77+ adult mice and P10 and P2 neonates were investigated by
p63 immunostaining. Within the corneal epithelium of both genotypes at all ages p63-
positive nuclei were present in the basal layer. The distribution of p63-positive nuclei in the
basal layer of the corneal epithelium was analyzed as for BrdU at all ages (Fig. 4C,D). There
was no significant difference in the proportion of p63-expressing cells between peripheral
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and central regions of either genotype at P2 (wild-type P = 0.33; PAX77+ P = 0.38), P10
(wild-type P = 0.68; PAX77+ P = 0.099), or in adults (wild-type P = 0.0652; PAX77+ P =
0.104). The percentage of p63-positive cells was higher in PAX77+ than wild-type in both
peripheral and central regions of the cornea. This finding was not significant at P2 (PAX77+
peripheral mean ± SEM 64.44 ± 5.02% vs. wild-type 54.17 ± 4.04%, P = 0.129 by unpaired
t-test; PAX77+ central mean ± SEM 70.36 ± 4.48% vs. 59.66 ± 3.64%, P = 0.097 by
unpaired t-test) but became significant at P10 (PAX77+ peripheral mean ± SEM 52.35 ±
3.17% vs. wild-type 43.17 ± 2.07%, P < 0.05 by unpaired t-test; PAX77+ central mean ±
SEM 59.38 ± 2.57% vs. wild-type 41.16 ± 4.25%, P < 0.01 by unpaired t-test) and in adults
(PAX77+peripheral mean ± SEM 58.38 ± 2.68% vs. wild-type 46.03 ± 2.1%, P < 0.001 by
unpaired t-test; PAX77+ central mean ± SEM 52.5 ± 2.68% vs. wild-type 37.09 ± 4.1%, P <
0.01 by unpaired t-test; Fig. 4).
No Abnormal Apoptosis in PAX77+ Corneal Epithelia
We hypothesized that increased cell proliferation in the PAX77+ corneal epithelium may be
compensating for pathological apoptotic events secondary to increased Pax6 dosage.
However, no Caspase-3 activity was noted by immunohistochemistry in corneal epithelia of
either genotype at any age. The terminal deoxynucleotidyltransferase-mediated UTP end-
labeling (TUNEL) labeling revealed apoptotic cells only in the superficial layer of the
corneal epithelium in both genotypes, consistent with patterns of apoptosis only in
desquamating cells as described previously (Ren and Wilson, 1996). No unusual apoptotic
events were noted in PAX77+ epithelia, and no difference was noted between the two
genotypes (Fig. 4D).
K12 Expression Is Delayed and Reduced in PAX77+ Corneal Epithelia
No defect in epithelial cells was noted by any of the four markers assaying different
parameters of the cell cycle (above), and in fact, the results suggested that proliferation was
higher in PAX77+ than in wild-type. This finding recapitulates results obtained for Pax6+/-
by Davis et al. (2003) and Ramaesh et al. (2005a). In Pax6+/- corneas, it was hypothesized
that corneal fragility mediated by reduced cytokeratin-12 (K12) expression leads to
increased cell desquamation and increases the proliferation rate in compensation (Davis et
al., 2003). To determine K12 expression in PAX77+ corneas, K12 immunohistochemical
staining was performed on one eye of six adult mice and six 10-day-old neonates of each
genotype. Levels of K12 expression were, on average, lower in PAX77+ eyes than wild-
type. As previously reported (Ramaesh et al., 2003, 2005a), the entire corneal epithelium of
the wild-type eye is positive at all ages examined. K12 expression was much stronger in
adult sections than at P10. The PAX77+ eyes showed a range of different staining patterns in
the corneal epithelium. In the central corneal epithelium of the adult PAX77+ mice most
sections showed positive staining, while some showed patchy staining, with few of the
samples showing negative staining in the central regions. In PAX77+ corneas, the central
regions show more robust K12 expression when compared with peripheral regions at both
P10 and in adults (Fig. 5A,B). By quantified Western blot, K12 expression in PAX77+
corneas was on average 0.62× that in wild-type (n = 8 corneas, expression normalized
against β-actin; Fig. 5C).
Wound Healing Is Delayed in PAX77+ Corneal Epithelia
Circular epithelial wounds of diameter 0.8 mm were made in corneas of adult PAX77+ mice,
Pax6+/- mice, and their wild-type littermates, all on the same CBA/Ca genetic background.
The rate of healing was measured as described in the Experimental Procedures section.
Healing rates of both Pax6+/- and PAX77+ epithelia were significantly slower than wild-type
in control medium without serum or growth factors, and this retarded migration was
maintained for 24 hr (Fig. 6).
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We found that addition of 10% fetal calf serum to culture medium improved the rate of
Pax6+/- corneal epithelium wound healing to 23.4 ± 3.01 μm/h, equivalent to wild-type
(22.8 ± 4.56 μm/h), but had no significant effect on PAX77+ corneas (15.7 ± 3.4 μm/h).
Previously (Leiper et al., 2006), we showed that epidermal growth factor (EGF) could
improve wound healing in Pax6+/- corneal epithelial cell monolayers in vitro by increasing
the wound-induced waves of calcium and ERK1/2 signalling. Addition of 10 ng/ml EGF to
the wound system described in this study (in absence of serum) also caused a significant
increase in healing rates of Pax6+/- epithelia (Fig. 6A,B). In contrast, EGF was found to have
no effect on wound healing rates of PAX77+ corneas. Western blots were performed to
assay levels of EGF-receptor (EGFR) in the PAX77+ corneas, which was found to be 2.64-
fold higher than wild-type (data normalized against β-actin expression, n = 2 blots of each
genotype, each protein sample from four corneas; Fig. 6C). Failure of PAX77+ corneas to
respond to EGF was not, therefore, because the receptor was not expressed—EGFR levels
rise in proportion to Pax6 dosage. A summary of all quantitative data is presented in
Supplementary Table S1.
Defects in the PAX77+ Lens
Transgenic overexpression of Pax6 isoforms in lens fibers has previously been shown to
cause failure of normal lens fiber differentiation, leading to cataract (Duncan et al., 2000,
2004). The lens phenotype of the PAX77+ model was also investigated. At the gross level,
vacuoles were observed in lens from P2 (Fig. 7A,B), suggesting failure of lens fiber
specification or elongation (n = 8). The lens bow region appeared normal, with nuclear
localization of the transcription factor Prox1, which is required for fiber differentiation (Fig.
7C,D; Duncan et al., 2002). β-crystallins were expressed in lens fibers but not the lens
epithelium (in a pattern identical to wild-type), and at the level of Western blot, although
Pax6 was up-regulated compared with wild-type, β-crystallin isoforms were not down-
regulated (Fig. 7E-G). Although the lens epithelium was grossly normal at P2, in adults, it
became disrupted, with elongation to posterior regions of the lens and in some cases it was
interrupted, with ectopic lens bows (Fig. 7H and Supplementary Figure S2). Consistent with
partial failure of lens fiber differentiation, Pax6-positive cell nuclei were observed in the
lens fiber region of all PAX77+ lenses (n = 7); some nuclei from labeled animals were
BrdU-positive, indicating active mitosis (Fig. 7I,J). No Pax6 or BrdU-positive nuclei were
observed in any adult wild-type control lens.
DISCUSSION
What Controls Growth of the Cornea: PAX77+ as a Mouse Model of Microcornea?
Little is known about the molecular or cellular control of corneal growth. In humans at birth,
the cornea is approximately 90% of its adult diameter, and while the cornea reaches its final
diameter by about the age of 3, the rest of the eye continues to grow for several more years
(Oyster, 1999). We found that wild-type mouse corneas are less than 50% adult size at birth.
In contrast, in PAX77+ mice, while the corneal diameter is only slightly smaller than wild-
type at birth, it subsequently fails to grow fully, and on average is already 90% of its final
adult size (Fig. 2). Postnatal growth of the posterior segment of the PAX77+ eye appears
effectively normal in most cases, giving the mice a microcornea phenotype. This may
suggest that the PAX77+ mouse is a model of microcornea, but given that the dynamics of
corneal growth in the PAX77+ are similar to that seen in human, it may be better to regard
wild-type mice more as a model of human megalocornea.
During the process of normal corneal growth, keratocytes produce regular arrays of collagen
fibrils that constitute the bulk of the corneal stroma. A model of microcornea whereby
keratocytes differentiate as normal but subsequently fail to produce normal quantities of
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collagen (Oyster, 1999) would perhaps be consistent with the patterns of corneal growth
failure seen in the PAX77+ mice. However, corneal thickness has not been adversely
affected in the PAX77+, suggesting that any defect is restricted to tangential and radial
collagen extension in the plane of the corneal circle. No such defect was observed by
transmission electron microscopy in this study.
Although the data are equivocal, both total eye size and corneal diameter are at least in part
modulated by intraocular pressure (IOP) during critical stages of growth (Coulombre, 1956,
1957; Neath et al., 1991; Schmid et al., 2003). IOP is in turn modulated by the secretory
activity of the ciliary epithelium (Forrester et al., 2002), so there is a conceptual link
between the morphological defects within the anterior eye and the microphthalmia/
microcornea phenotypes in the mice.
K12—Delayed/Abnormal Differentiation
Previous results (Ramaesh et al., 2003, 2005a) showed that K12 is expressed throughout all
cell layers of the wild-type corneal epithelium from 2 weeks after birth. Ramaesh et al.
(2005a) noted that expression of K12 was delayed in Pax6+/- eyes, but improved with age.
Unexpectedly, expression of K12 was also reduced in the PAX77+ corneal epithelia
compared with the wild-type, and there was some evidence of improvement with age (Fig.
5). In the Pax6+/- mouse, it was hypothesized that there was a decrease in K12 expression
resulting in increased corneal fragility, which leads to increased cell loss and resulted in an
increased cell proliferation rate to compensate (Davis et al., 2003). K12 deficiency has a
disruptive effect on the structure of the corneal epithelium (Kao et al., 1996). In K12-/- mice,
the number of keratin intermediate filaments in basal and suprabasal layers of the corneal
epithelium is reduced and they appear as dense bundles rather than the normal fine
filamentous networks that are normally seen (Kao et al., 1996). Also, the corneal epithelial
layer becomes thinner and fragile, as a result corneal epithelial cells are unable to adhere
firmly on to the corneal surface (Lu et al., 2001). This finding would suggest that K12
deficiency leads to a problem in corneal epithelial maintenance and a fragile corneal
epithelium, which might underlie the increased cell proliferation seen in mice which both
under- and overexpress Pax6.
Effect of Increased Pax6 Dosage on Cell Proliferation and Cell Cycle Progression
The cell cycle is driven by a family of cyclin-dependent protein kinases (CDKs), which are
regulated in turn by cyclins whose synthesis, unlike the CDKs, is cell cycle-dependent
(Draetta, 1991). There are four groups of cyclins: D, E, A, and B (Sherr, 1993). Expression
of cyclin E, used in this study, is initiated in mid-G1 phase; maximal expression is occurs at
the time of entry into S phase; and degradation occurs as the cell progresses through S phase
(Sherr, 1993; Chung et al., 1999). Once cells have passed through the “restriction point” of
G1 phase of the cell cycle, they are committed to pass through the remainder of the cell
cycle (Chung et al., 1999); therefore, cells expressing cyclin E can be said to be actively
progressing through the cell cycle.
None of the cell cycle assays we used, i.e., BrdU incorporation, cyclin E, and p63
expression, suggested any failure of cell cycling in PAX77+ corneal epithelia in vivo.
TUNEL labeling does not indicate a difference in cell loss through apoptosis between the
two genotypes and, therefore, an increase in apoptosis probably does not account for the
increase in proliferation that is seen in the PAX77+.
In contrast, Ouyang et al. (2006) showed that Pax6 overexpression in vitro in a rabbit
corneal epithelial cell line and rabbit primary cells retarded cell proliferation in a dose-
dependent and cell autonomous manner, by blocking progression through the cell cycle.
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Pax6 up-regulation also increased apoptosis up to fourfold by a Caspase-3-independent
mechanism in that study. In this respect, it was perhaps surprising that we did not find any
negative effect on proliferation in PAX77+ corneal epithelia. However, the levels of Pax6
protein in adult PAX77+ eyes were not as exaggerated as those promoted by the inducible
system in Ouyang et al. (2006). Another source of variability between this study and that of
Ouyang et al., is that, as Pinson et al. (2005) suggested, the relative ratios of the Pax6 and
Pax6(+5a) isoforms may be as important to downstream gene regulation as the dosage of the
gene per se. By Western blot, we found no significant difference between the endogenous
Pax6:Pax6(5a) ratio and that in the PAX77+ mouse, but this was not the case for the
inducible system described by Ouyang et al. (2006), in which only one isoform was
overexpressed. The differences may also reflect the additional complexity of the in vivo
situation (with cell loss, tissue-tissue interactions modulated by a variable environment) over
the in vitro cell monolayer system, which serves a different purpose in examining only the
autonomous effects of Pax6 overexpression in a controlled simple system. It would appear
that the corneal epithelium is maintained in the PAX77+ mouse in a regulated system that
acts despite the autonomous tendencies of Pax6 to retard the cell cycle and promote
apoptosis in epithelial cells.
It was considered possible that, because the lens acts as an organizer of anterior segment
development and has previously been shown to be particularly sensitive to Pax6 dosage, the
corneal phenotype observed in PAX77+ may be a secondary consequence of increased
dosage of Pax6 in the lens (Coulombre and Coulombre, 1964; Thut et al., 2001; Collinson et
al., 2001). However, previous models of lens-specific Pax6 isoform overexpression (Duncan
et al., 2000, 2004) did not report microcornea, suggesting that corneal Pax6 dosage is the
primary cause of the corneal phenotype seen here. The lens phenotype reported in this study,
at P2 (hence before the onset of the corneal phenotype), is superficially similar to that
reported in Duncan et al. (2000, 2004).
Wound Healing in PAX77+ Mice
We found that both Pax6+/- and PAX77+ corneal epithelia heal more slowly than wild-type
in ex vivo whole eye organ culture in defined medium without serum. Addition of fetal calf
serum to Pax6+/- corneal epithelia ex vivo cultures dramatically increased the rate of wound
healing to at least wild-type levels (comparable to results obtained previously for Pax6+/-
corneal epithelia by Ramaesh et al. [2006] in serum-supplemented medium) but did not
affect wild-types or PAX77+ corneas. These data are interesting for several reasons. First, it
appears that wild-type eyes are self-sufficient for all the cytokines and growth factors
required to maintain wound healing, in the absence of continuing vascular and nervous
supply, such that addition of exogenous serum does not improve corneal performance.
Second, that Pax6+/- are deficient in at least one of these cytokines and growth factors, but
are capable of migrating at wild-type levels if serum is applied exogenously. In this study,
we found that addition of EGF alone did not affect wild-type corneas, but corrected the
wound healing rate Pax6+/-, consistent with our previous work on murine corneal epithelial
monolayers (Leiper et al., 1996) and suggesting that modulation of the EGF signalling
pathway may offer a therapeutic strategy for the corneas of aniridic patients. Third, although
PAX77+ corneal epithelia are also deficient in wound healing in serum-free medium, a
superficial similarity with Pax6+/-, the deficiency is not related to lack of growth factors,
because addition of serum or EGF to defined medium does not increase the rate of PAX77+
cell migration.
Previously we suggested that failure of prompt wound healing in Pax6+/- mice might
underlie long-term degeneration leading to opacity (Leiper et al., 1996), and we have shown
in two systems (corneal epithelial cell monolayers and whole eye culture) that Pax6+/- cells
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show a delayed wounding response. However, the PAX77+ mice suggest that corneal
transparency can be maintained despite very severe wound healing defects.
Similarities and Differences Between PAX77+ and Pax6+/-
Previous work emphasized the similarity between the phenotype of Pax6+/- and PAX77+
mice, suggesting that both over- and underexpression of Pax6 led to equivalent eye
abnormalities. We have now more explicitly compared the eyes of these two strains,
summarized in Table 2, and at the molecular level there are some surprising similarities.
Cell proliferation is increased in both Pax6+/- and PAX77+, and expression of cytokeratin-12
was reduced in both. While proliferation rate is a function of a balance between multiple
factors affecting cell loss and stem cell activity, potentially several steps downstream of
direct Pax6 target genes, the reduction of cytokeratin-12 expression in Pax6+/- and PAX77+
corneas is unexpected because K12 is reported to be a direct transcriptional target of Pax6
(Liu et al., 1999). In microarray analysis of the lens (Chauhan et al., 2002b), proportionately
few of the identified Pax6 downstream genes were both down-regulated in Pax6+/- and up-
regulated in Pax6 overexpressing lenses, suggesting that gene transcription profiles in
tissues with different Pax6 dosages are neither simple nor intuitive.
EXPERIMENTAL PROCEDURES
Mice
PAX77+ transgenics were maintained on the CBA/Ca genetic background (known as
“CBA77”), breeding PAX77+ × “wild-type” PAX77- CBA/Ca to produce hemizygous
PAX77+ and wild-type littermates. PAX77+ mice were identified by their eye size and their
genotype confirmed by polymerase chain reaction (PCR). Mice were killed by cervical
dislocation, and the eyes were immediately removed and fixed in 4% paraformaldehyde
(PFA) or the eyes were immediately wounded and then removed for culturing. For BrdU
labeling experiments, mice of mass 25-32 g were injected with 0.2 ml of 10 mg/ml BrdU in
saline 4 hr before death. Adult mice in this study were taken at 8-15 weeks old.
Histological Analysis
Eyes were fixed in 4% PFA for 2 hr, then processed to wax, and 7-μm sections were cut.
Eyes were sectioned in an anterior-posterior plane to include cornea, lens, and retina.
Histological features of the cornea of PAX77+ and wild-type littermates at P2, P10, and
adult were then compared. For PAS staining, slides were treated with periodic acid, 15 min,
washed, and stained with Schiff’s reagent, 5 min.
Morphometric Measurements
Corneal diameter was measured in PAX77+ and wild-type P2, P10, and adult eyes using a
stereomicroscope. Tissue sections of adult cornea were viewed under a light microscope
(×40 objective), and measurements were made using a calibrated eyepiece graticule. The
thickness of the corneal epithelium and the whole cornea were measured in three places (two
peripheral regions and one central) in 5 of the middle 13 serial sections of each eye (mid - 6,
mid - 3, midsection, mid + 3, mid + 6). Mean thicknesses were calculated for both the
central and peripheral cornea. The number of cell layers in the corneal epithelium was also
counted in the same sections allowing the mean cell layers for each eye to be calculated.
Immunohistochemical Staining
Deparaffinized sections were washed in 100% ethanol, incubated with 3% hydrogen
peroxide, 20 min, in methanol, to block endogenous peroxidase activity, re-hydrated with
70% ethanol and washed with phosphate buffered saline (PBS). Antigen retrieval was
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performed by boiling in 0.01 M citrate buffer, pH 6, 20 min. Slides were washed with Tris-
buffered saline (TBS: 100 mM Tris, 0.9% NaCl, pH7.6) and blocked with 4% normal serum
(species according to secondary antibody) in TBS, 0.3% bovine serum albumen, 2 hr at
room temperature. Primary antibody incubation overnight at 4°C (P63: Santa Cruz sc-8431
diluted 1:200; Pax6: Developmental Studies Hybridoma Bank, University of Iowa diluted
1:500; BrdU: BD Biosciences 347580, diluted 1:200; cyclin E: Santa Cruz sc-481, diluted
1:200; K12: Santa Cruz sc-17101, diluted 1:400; Prox1: Sigma P7124, diluted 1:300; β-
crystallin Santa Cruz sc-22745, diluted 1:100). Slides were washed in TBS and then treated
with the secondary antibody (P63, Pax6, and BrdU: Dakocytomation UK Ltd, biotinylated
rabbit anti-mouse IgG diluted 1:200 in blocking buffer; cyclin E: Sigma biotinylated goat
anti-rabbit IgG; K12: Invitrogen Alexa 488 donkey anti-rabbit A21206 or Alexa 488 goat
anti-mouse IgG1 A21121 diluted 1:500 in blocking buffer) for 45 min then washed in TBS.
All slides for which a nonfluorescent secondary was used were treated with avidin-biotin
complex (ABC; Dakocytomation UK Ltd) for 30 min washed with TBS and 20mM Tris pH
7.5. The binding antibody was then visualized by 3,3′-diaminobenzidine (DAB) stain (5.9
ml of 20 mM Tris pH 7.6, 100 μl of 50 mg/ml DAB, 1 μl of H2O2). Control slides were
treated with normal blocking buffer without primary antibody, but otherwise treated
normally. Fluorescence immunohistochemistry was quantified by grabbing individual nuclei
from wild-type and PAX77+ sections processed in parallel and immunostained on the same
slides, and measuring their luminosity in Adobe Photoshop7.
Analysis of P63, cyclin E, and K12 Expression Patterns and BrdU Incorporation
For quantitative analysis of P63, cyclin E, and BrdU, each cell in the basal cell layer was
scored as either positive or negative along the entire length of the corneal epithelium. Fully
intact corneal sections from central serial sections were scored. Mid regions of the cornea
were split into four equal sections with the outer sectors representing the peripheral cornea
and inner sectors the central cornea (Fig. 4). The distribution of P63, cyclin E, and BrdU
was calculated separately for the peripheral and central corneal in both PAX77+ and wild-
type littermates.
K12 expression was scored separately in the peripheral and central cornea in PAX77
mutants and wild-type mice at various ages. Ten serial sections obtained from the middle of
each eye were scored for K12 staining pattern as positive, negative, or “patchy” similar to
the scoring system in Ramaesh et al. (2005a). For descriptive purposes, positive epithelia
were defined when all cells exhibited staining throughout the epithelium above background
of labeling by normal rabbit serum. Negative staining indicated background only. In patchy
stained epithelium, staining was heterogeneous, with some cells clearly positive and others
at or around background levels.
Apoptosis
The TUNEL in situ cell death detection kit, fluorescein (Roche Diagnostics) was used to
label apoptotic cells in the corneal epithelium of tissue sections. Dewaxed sections were
exposed to proteinase K (80 μg/ml) for 5 min at room temperature. Slides were washed
three times in PBS. One slide was treated with DNAse1 as a positive control (50 units/ml
DNAse1 in 50 mM Tris-HCl pH 7.5, 1 mM MgCl 1 mg/ml BSA for 30 min at 37°C,
followed by three 5-min washes in PBS). TUNEL labeling was then performed per the
manufacturer’s instructions. Slides were then washed three times for 5 min in PBS and
mounted in Vectashield (VectorLabs, UK).
Western Blot Analysis
Whole corneas were dissected from the eyes into lysis buffer. The cornea was subjected to
10% sodium dodecyl sulfate-polyacrylamide gel elecrophoresis, and transferred to a
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nitrocellulose membrane. After blocking, the blots were incubated with primary antibody
(anti-mouse Pax6 monoclonal antibody [1:2,000] or total EGFR monoclonal antibody
[1:1,000] overnight at 4°C), washed, and then treated with the secondary antibody anti
mouse IgG horseradish peroxidase (1:3,000) for 1 hr at room temperature. The blot was then
washed and visualized by the ECL system according to the manufacturer’s instructions.
Corneal Epithelial Wound Healing
A trephine blade of diameter 0.8 mm was used to introduce a wound in the center of the
cornea, under a dissecting microscope. An ophthalmological scalpel was used to de-bride
the corneal epithelium within the wound. The wound area in both PAX77+ and PAX77-
mice was visualized by topical application of sodium fluorescein and photographed with a
digital camera on a dissecting microscope. The eyes was then enucleated and placed into a
culture wells (corneas facing up) containing Keratinocyte Basal Medium (Cambrex, UK),
DMEM/HAM F-12, 25 mM HEPES buffer, 125 μg/ml gentamycin and 125 μM 2-β-ME
(Hazlett et al., 1996). Unless otherwise stated, the culture medium contained no fetal bovine
serum. To determine the role of EGF in modulating wound healing, 10 ng/ml murine EGF
(Sigma, Poole, UK) was added. Eyes were maintained at 37°C in 5% CO2 and allowed to
heal with the wound area being visualized and photographed at set time points. Reduction in
wound area was observed over time and continued for over 24 hr under these conditions.
The change in wound diameter over time was measured and calculated using Adobe
Photoshop Pro.
Statistical Analysis
Unpaired t-tests were used to compare results obtained in the PAX77+ and wild-type
littermates.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Histological analysis of the anterior segment of the eye of the PAX77+ transgenic mice.
A,B: Comparison of the corneas of postnatal day (P) 10 wild-type (A) shows the corneal
epithelium is stratified and is made up of two to three cell layers; the same pattern is seen in
the PAX77+ (B). C,D: In the adult comparison of the corneal sections of both wild-type (C)
and PAX77+ (D) revealed that the PAX77+ corneal epithelium was relatively normal.
Quantitative analysis (see text) showed that, on average, it was composed of fewer cell
layers than wild-type. E,F: Transmission electron microscope image of corneal stroma of
wild-type (E) and PAX77+ (F) corneal stroma, showing that the interfibrillary gaps in (C)
and (D) are processing artifacts and that collagen fiber lamination is normal in PAX77+. G:
A normal ciliary body seen in the adult wild-type (arrowhead). H: Lack of a ciliary body
(arrowhead) and iris hyperplasia in the PAX77+. l, lens; c, cornea. Scale bar = 50 μm in A-
D, 2 μm in E,F.
Dorà et al. Page 15
Dev Dyn. Author manuscript; available in PMC 2009 March 13.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 2.
Corneal morphometry. A: Comparison of cornea diameter (mm) in PAX77+ and wild-types
age postnatal day (P) 2, P10, and adult. B: Comparison of thickness of central (C) and
peripheral (P) regions of the cornea in adult PAX77+ and wild-type mice. *P < 0.01, ***P <
0.0001 by unpaired t-test.
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Fig. 3.
Pax6 expression. A: Pax6 immunohistochemical staining in PAX77+ and wild-type eyes at
postnatal day (P) 2, P10, and in adults. Pax6 expression in the cornea is increased in the
PAX77+ at postnatal day 2 and postnatal day 10. B,C: Increased Pax6 expression in the
cornea of the PAX77+ adults was confirmed by Western blot, and shown to be statistically
significant when quantified and normalized against β-actin expression (C). Scale bar = 30
μm.
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Fig. 4.
Corneal epithelial proliferation. A,B: Frequency of bromodeoxyuridine (BrdU) -positive
cells in the basal layer of the corneal epithelium in central and peripheral regions of the
cornea in adult wild-type and PAX77+ mice. C: Distribution of p63-expressing cells in the
peripheral and central cornea of the basal layer of the corneal epithelium of wild-type and
PAX77+ eyes in adults and postnatal day (P) 10 and P2 neonates. D: Immunohistochemical
staining to visualize p63-positive cells in the wild-type corneal epithelium.
Immunohistochemical staining to identify proliferating cells in the wild-type corneal
epithelium that have incorporated BrdU. Terminal deoxynucleotidyltransferase-mediated
UTP end-labelling (TUNEL) labeling (green) of apoptotic cells in the superficial layers of
the wild-type and PAX77+ corneal epithelium. 4′,6-diamidine-2-phenylidole-
dihydrochloride (DAPI) nuclear counterstain is visible.
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Fig. 5.
Cytokeratin-12 expression. A,B: Bar charts grouping samples by K12 expression in both
peripheral and central regions of the cornea in both wild-type and PAX77+ mice in adults
(A) and postnatal day 10 (B). Bars are divided to represent the frequency of positive, patchy,
and negatively stained samples. C: Western blot of K12 expression in wild-type and
PAX77+ corneas.
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Fig. 6.
Wound healing. A: Histogram showing change in wound diameter (i.e., amount of healing)
at 12 and 24 hr after wounding, in wild-type, Pax6+/-, and PAX77+ eyes cultured in serum-
free culture medium ± 10 ng/ml epidermal growth factor (EGF). B: Representative images
of a single wild-type eye immediately after wounding and 6 hr and 12 hr after wounding,
showing complete closure of the wound after 12 hr. The wounds were topically stained with
fluorescein to visualize the wound area. C: Western blot analysis of EGF receptor (EGFR)
expression in wild-type and PAX77 whole cornea, showing increased expression of EGFR
in the PAX77+. Each lane was pooled from four separate corneas.
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Fig. 7.
Lens defects. A-F: Histology of postnatal day (P) 2 wild-type (A,C,E) and PAX77+ (B,D,F)
lenses, with hematoxylin and eosin staining (A,B), anti-Prox1 immunohistochemistry (C,
D), and anti-β-crystallin (E,F). G: Western blot analysis of Pax6 and β-crystallins in the
PAX77+ lens. H: Lens epithelial dysgenesis in a PAX77+ lens. Top of image is anterior.
Green arrowheads represent lens bows of displaced and fragmented epithelium. A composite
high-resolution image is presented as Supplementary Figure 2. I,J: Ectopic nuclei in adult
PAX77+ lens fiber region are Pax6-positive (I) and, with low frequency, BrdU-positive.
Scale bars = 500 μm in A,B, 50 μm in C,D, 320 μm in H, 50 μm in I, 10 μm in J.
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